Thursday, March 30, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

CBRNE Mass Casualty: Rapid Bedside Ultrasound Triage System Awarded BARDA Investment

by Global Biodefense Staff
October 29, 2021
CBRNE Mass Casualty: Rapid Bedside Ultrasound Triage System Awarded BARDA Investment

Credit: Rivanna via MedicalCountermeasures.gov

A portable, radiation-free alternative for fracture screening may help reduce the need for limited X-rays resources – the equipment, as well as the physical space and specially trained personnel required for X-rays – in a mass casualty incident, such as a radiological or nuclear emergency.

BARDA has partnered with RIVANNA to develop the Accuro XV toward U.S. market entry. BARDA will support the advanced research and development of the Accuro XV from a benchtop prototype to a fully functional, market ready fracture detection device with decision-assist technology to help advance emergency medicine.

RIVANNA®, developers of imaging-based medical solutions, announced that they have received a contract from the Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), for the design and development of a computer-aided 3D fracture detection and diagnosis product, called Accuro® XV. HHS/ASPR/BARDA will provide $11.6 million over 24 months with options for additional funding for supporting further development up to $65 million. 

The Accuro XV is a portable, computer-aided, 3D fracture detection and diagnosis system based on ultrasound imaging. The device is intended for rapid, radiation-free, bedside fracture triage. If development is successful, such a device may help reduce bottlenecks in routine care and mass casualty blast trauma incidents by quickly providing a detailed digital visualization of an injury site and determining whether a fracture is present.

This approach may enable emergency departments to fast-track care for the large number of low severity, simple fractures and sprains.

In the wake of any chemical, biological, radiological, or nuclear (CBRN) incident, easily deployable triage tools are needed to help save lives and enable a rapid response. Blast-related trauma typically includes multi-system, life-threatening injuries that demand swift triage and treatments either in the field or in the emergency rooms. Overwhelming numbers of trauma patients are anticipated in the immediate aftermath of a CBRN incident, and it is vital to conserve X-ray resources for the highest priority patients. The Accuro XV helps make that possible by enabling rapid triage of fracture severity.

Additionally, the Accuro XV’s cart-based device is designed to be portable, which would enable the device to be deployed in multiple environments. These features could help meet the CBRN Burn/Blast Program’s objectives of improving care by reducing bottlenecks and of addressing care of fractures and extremity injuries, which account for more than half of all injuries in mass casualty incidents. The advancement of field-deployable equipment aligns with BARDA’s commitment to developing medical countermeasures that are fast, accurate, and able to be used in a wide array of settings.

Tags: ASPRAwardsBARDABlast InjuryEditor PickEmergency MedicineHHSMass Casualty

Related Posts

small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development
Industry News

DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
Load More

Latest News

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy